Company: GRAN
Filing Date: 2025-04-09
Form Type: CORRESP
Source: 0001213900-25-030181
Chunk: 0

Company: Grande Group Ltd/HK
Filing Date: 2025-04-09
Form: CORRESP
Chunk 0
---
<div align='center'>Grande Group Limited

Suite 2701, 27/F, Tower 1

Admiralty Center, 18 Harcourt Road

Admiralty, Hong Kong</div>

April 9, 2025

Division of Corporation Finance

Office of Finance

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

| Attention: | Robert Arzonetti |
|            | James Lopez      |
|            | Victor Cecco     |
|            | Lory Empie       |

| Re: | Grande Group Limited                                 
 Amendment No.2 to Registration Statement on Form F-1 
 Filed March 14, 2025                                 |
|:----|:-----------------------------------------------------|
|     | File No.333-283705                                   |

Ladies and Gentlemen:

This letter is being submitted in response to
the letter dated March 31, 2025, from the U.S. Securities and Exchange Commission (the “Commission”) in which the staff of
the Commission (the “Staff”) commented on the above-referenced Registration Statement on Form F-1 filed on March 14, 2025.
Concurrently with the submission of this letter, we hereby transmit, via EDGAR, an amended Registration Statement on Form F-1/A (“Form
F-1/A”) for filing with the Commission, which has been revised to reflect the Staff’s comments as well as certain other updates
to the Form F-1.

For the Staff’s convenience, the Staff’s
comment has been stated below in its entirety, with the Company’s response set out immediately underneath such comment. Page references
below in the Company’s responses are to the page numbers in Form F-1/A. Capitalized terms used but not otherwise defined herein
have the meanings set forth in the Form F-1/A.

| 1. | This sub-section appears to discuss two separate issues. The first, is the impact on you and this offering in particular from the Trial Administrative Measures. The second is the impact of those measures where you provide advisory and other services for businesses in the PRC as they attempt to offer securities or otherwise raise capital in Hong Kong. Given the substantial potential impact of the Trial Measures on your business servicing PRC based clients, please revise this section to discuss those impacts under an appropriate heading. Also, revise to clarify aggregate amount of your overall advisory and other services you provide to PRC based companies. |

RESPONSE: